Literature DB >> 8653544

Visceral fat accumulation and cardiovascular disease.

Y Matsuzawa1, T Nakamura, I Shimomura, K Kotani.   

Abstract

Classification of Obesity. It has been noted that the incidence of metabolic complications among equally obese subjects differs depending on their physique (11) and there has been more scientific assessment in recent years that complications such as diabetes mellitus or hyperlipidemia are related to adipose tissue distribution (5). In 1983, we reported a method for adipose tissue analysis using computed tomography (CT), which enables the analysis of adipose tissue in the body cavity, e.g., abdominal cavity or thoracic cavity, as well as subcutaneous fat (10). Using this method, we found that the patients with accumulation of fat in the abdominal cavity have a higher incidence of complication (1). Based on this finding, we proposed a classification into visceral fat obesity by visceral fat area (V)/subcutaneous fat area (S) ratios obtained from CT cross sectional pictures of the umbilical region. We divided obese subjects at a V/S ratio of 0.4, classifying those with a ratio of 0.4 or more as a visceral fat obesity group and those with V/S ratio of below 0.4 as a subcutaneous fat obesity group. Disorders of glucose and lipid metabolism were more marked in the visceral fat obesity than subcutaneous fat obesity even when sex and age were matched. We also demonstrated that visceral fat obesity is more frequently accompanied by circulatory disorders such as left ventricular enlargement (8) and hypertension than subcutaneous fat obesity (2).

Entities:  

Mesh:

Year:  1995        PMID: 8653544     DOI: 10.1002/j.1550-8528.1995.tb00481.x

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  36 in total

1.  Topical ER36009, a RARgamma-selective retinoid, decreases abdominal white adipose tissue and elicits changes in expression of genes related to adiposity and thermogenesis.

Authors:  Tomohiro Sakuta; Taro Uchiyama; Toshiji Kanayama
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

2.  Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice.

Authors:  Angela Burgess; Ming Li; Luca Vanella; Dong Hyun Kim; Rita Rezzani; Luigi Rodella; Komal Sodhi; Martina Canestraro; Pavel Martasek; Stephen J Peterson; Attallah Kappas; Nader G Abraham
Journal:  Hypertension       Date:  2010-11-01       Impact factor: 10.190

3.  Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Luca Busetto; John Dixon; Maurizio De Luca; Scott Shikora; Walter Pories; Luigi Angrisani
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

4.  Lower serum level of adiponectin is associated with increased risk of endoscopic erosive gastritis.

Authors:  Shunsuke Yamamoto; Kenji Watabe; Shusaku Tsutsui; Shinichi Kiso; Toshimitsu Hamasaki; Motohiko Kato; Yoshihiro Kamada; Yuichi Yoshida; Shinji Kihara; Miyuki Umeda; Aiko Furubayashi; Kazuo Kinoshita; Osamu Kishida; Takashi Fujimoto; Akira Yamada; Yoshifumi Tsukamoto; Norio Hayashi; Yuji Matsuzawa
Journal:  Dig Dis Sci       Date:  2011-03-30       Impact factor: 3.199

5.  Serum adipocyte fatty acid-binding protein is independently associated with complex coronary lesions in patients with stable coronary artery disease.

Authors:  Masahito Kajiya; Toru Miyoshi; Masayuki Doi; Shinichi Usui; Mutsumi Iwamoto; Ko Takeda; Kazumasa Nosaka; Rie Nakayama; Satoshi Hirohata; Shozo Kusachi; Kazufumi Nakamura; Hiroshi Ito
Journal:  Heart Vessels       Date:  2012-12-09       Impact factor: 2.037

6.  Visceral fat and prevalence of hypertension among African Americans and Hispanic Americans: findings from the IRAS family study.

Authors:  Capri G Foy; Fang-Chi Hsu; Steven M Haffner; Jill M Norris; Jerome I Rotter; Leora F Henkin; Michael Bryer-Ash; Yii-Der I Chen; Lynne E Wagenknecht
Journal:  Am J Hypertens       Date:  2008-06-19       Impact factor: 2.689

7.  Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.

Authors:  Whalen Clark; Erin M Siegel; Y Ann Chen; Xiuhua Zhao; Colin M Parsons; Jonathan M Hernandez; Jill Weber; Shalini Thareja; Junsung Choi; David Shibata
Journal:  J Am Coll Surg       Date:  2013-03-21       Impact factor: 6.113

8.  Serum amyloid A3 does not contribute to circulating SAA levels.

Authors:  Tsuyoshi Chiba; Chang Yeop Han; Tomas Vaisar; Kentaro Shimokado; Atil Kargi; Mei-Hsiu Chen; Shari Wang; Thomas O McDonald; Kevin D O'Brien; Jay W Heinecke; Alan Chait
Journal:  J Lipid Res       Date:  2009-03-12       Impact factor: 5.922

9.  Intraperitoneal fat and insulin resistance in obese adolescents.

Authors: 
Journal:  Obesity (Silver Spring)       Date:  2009-08-27       Impact factor: 5.002

10.  Association analyses of the INSIG2 polymorphism in the obesity and cholesterol levels of Korean populations.

Authors:  Seongwon Cha; Imhoi Koo; Sun Mi Choi; Byung Lae Park; Kil Soo Kim; Jae-Ryong Kim; Hyoung Doo Shin; Jong Yeol Kim
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.